Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
Apte RN, Douvdevani A, Zoller M, White RM, Dvorkin T, Shimoni N, Huleihel M, Fima E, Hacham M, Voronov E, et al. Apte RN, et al. Folia Biol (Praha). 1994;40(1-2):1-18. Folia Biol (Praha). 1994. PMID: 7958060
Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
Voronov E, Weinstein Y, Benharroch D, Cagnano E, Ofir R, Dobkin M, White RM, Zoller M, Barak V, Segal S, Apte RN. Voronov E, et al. Cancer Res. 1999 Mar 1;59(5):1029-35. Cancer Res. 1999. PMID: 10070959
IL-1 was shown to be essential for the eradication of activated T lymphoma cells because injection of activated RO1 cells together with IL-1-specific inhibitors, i.e., the IL-1 receptor antagonist or the M 20 IL-1 inhibitor, reversed reduced tumorigenicity patterns and led …
IL-1 was shown to be essential for the eradication of activated T lymphoma cells because injection of activated RO1 cells together with IL-1 …
Interleukin-1--a major pleiotropic cytokine in tumor-host interactions.
Apte RN, Voronov E. Apte RN, et al. Semin Cancer Biol. 2002 Aug;12(4):277-90. doi: 10.1016/s1044-579x(02)00014-7. Semin Cancer Biol. 2002. PMID: 12147202 Review.
IL-1 is required for tumor invasiveness and angiogenesis.
Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. Voronov E, et al. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2645-50. doi: 10.1073/pnas.0437939100. Epub 2003 Feb 21. Proc Natl Acad Sci U S A. 2003. PMID: 12598651 Free PMC article.
Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.
Song X, Voronov E, Dvorkin T, Fima E, Cagnano E, Benharroch D, Shendler Y, Bjorkdahl O, Segal S, Dinarello CA, Apte RN. Song X, et al. J Immunol. 2003 Dec 15;171(12):6448-56. doi: 10.4049/jimmunol.171.12.6448. J Immunol. 2003. PMID: 14662844
The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.
Werman A, Werman-Venkert R, White R, Lee JK, Werman B, Krelin Y, Voronov E, Dinarello CA, Apte RN. Werman A, et al. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2434-9. doi: 10.1073/pnas.0308705101. Proc Natl Acad Sci U S A. 2004. PMID: 14983027 Free PMC article.
Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions.
Apte RN, Krelin Y, Song X, Dotan S, Recih E, Elkabets M, Carmi Y, Dvorkin T, White RM, Gayvoronsky L, Segal S, Voronov E. Apte RN, et al. Eur J Cancer. 2006 Apr;42(6):751-9. doi: 10.1016/j.ejca.2006.01.010. Epub 2006 Mar 10. Eur J Cancer. 2006. PMID: 16530403 Review.
64 results
Jump to page
Feedback